TP53 and colorectal carcinoma: Similarly, to examine the impact of TP53 mutation status, we introduced a similar interaction term—“tissue type (1 = CRC, 0 = normal) × TP53 mutation status (1 = mutant, 0 = wild-type)”—into the model.